Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Oliver Troise"'
Autor:
Rakhee Mistry, Timothy M. Rawson, Oliver Troise, Nabeela Mughal, Luke S. P. Moore, Stephen Hughes
Publikováno v:
BMC Infectious Diseases, Vol 22, Iss 1, Pp 1-7 (2022)
Abstract Background European Committee on Antimicrobial Susceptibility Testing (EUCAST) breakpoint criteria for methicillin-susceptible Staphylococcus aureus (MSSA) treatment with ceftriaxone are based upon high dose (4 g/day) rather than standard do
Externí odkaz:
https://doaj.org/article/a70932601443431b960562f2fd864b40
Publikováno v:
Clinical Infection in Practice, Vol 12, Iss , Pp 100079- (2021)
Externí odkaz:
https://doaj.org/article/2b2440d61aa2478d9cf448a16ce89b9f
Publikováno v:
Clinical Infection in Practice, Vol 10, Iss , Pp 100068- (2021)
Background: An outbreak of Extensively Drug Resistant (XDR) Salmonella Typhi (S. Typhi) has recently emerged from Pakistan. The strain is resistant to most first-line antibiotics, including cephalosporins, and has become a significant public health t
Externí odkaz:
https://doaj.org/article/8dfbe0df28b949dbb59eff4524ea9ae3
Autor:
Rakhee, Mistry, Timothy M, Rawson, Oliver, Troise, Nabeela, Mughal, Luke S P, Moore, Stephen, Hughes
Background European Committee on Antimicrobial Susceptibility Testing (EUCAST) breakpoint criteria for methicillin-susceptible Staphylococcus aureus (MSSA) treatment with ceftriaxone are based upon high dose (4 g/day) rather than standard dose (2 g/d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d8549d08fc815363b61a30a239146ca2
http://hdl.handle.net/10044/1/102142
http://hdl.handle.net/10044/1/102142
Autor:
Kevin J. Frost, Ryan A. Hamilton, Stephen Hughes, Conor Jamieson, Paul Rafferty, Oliver Troise, Abi Jenkins
BackgroundAmikacin is an aminoglycoside with activity against Gram negative pathogens. Updated EUCAST amikacin breakpoints for Enterobacterales and Pseudomonas aeruginosa included revised dosing recommendations of 25-30mg/kg to achieve key pharmacoki
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dbed718c3ab58a7b582d0c3366fcb3c5
https://doi.org/10.1101/2022.05.22.22275426
https://doi.org/10.1101/2022.05.22.22275426
Publikováno v:
JAC-Antimicrobial Resistance. 4
Background Over-diagnosis of infective aspiration pneumonia is common in healthcare settings and represents a potential for misuse of antimicrobial therapy. Methods A retrospective analysis was undertaken of all hospitalized patients treated for aspi
Autor:
Stephen H. Hughes, John Asumang, Luke S. P. Moore, Sandra Fahmy, Nabeela Mughal, Katie L Heard, Oliver Troise
Publikováno v:
JAC-Antimicrobial Resistance
Introduction The glycopeptide teicoplanin is commonly utilized to facilitate outpatient parenteral antimicrobial therapy (OPAT). Licensed for once daily maintenance dosing, teicoplanin’s long half-life allows for less frequent dosing (e.g. thrice w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3c2ef3ec59573aa902209274ee2806be
http://hdl.handle.net/10044/1/87065
http://hdl.handle.net/10044/1/87065
Publikováno v:
Clinical Infection in Practice, Vol 12, Iss, Pp 100079-(2021)
Autor:
Louise Olley, Stephen H. Hughes, Ashkan Sadighi, Oliver Troise, Hugo Donaldson, Amelia Benjamin
Publikováno v:
Clinical Infection in Practice, Vol 10, Iss, Pp 100068-(2021)
Background An outbreak of Extensively Drug Resistant (XDR) Salmonella Typhi (S. Typhi) has recently emerged from Pakistan. The strain is resistant to most first-line antibiotics, including cephalosporins, and has become a significant public health th